Search
Close this search box.

Overdose in Australia: Findings from Australia’s Annual Overdose Report 2024

Category

Date & Time

27/08/2024 12:00 pm

Location

Zoom

Join our webinar for expert insights on the latest data on overdose in Australia, as we launch Australia’s Annual Overdose Report 2024.

Penington Institute is pleased to invite you to our special webinar, offering an opportunity to engage with thought leaders and experts on overdose prevention in Australia.

This year, we are honoured to be joined by Medical Director of the Uniting Medically Supervised Injecting Centre (MSIC) in Sydney NSW, Dr Marianne Jauncey, for a special opening address, followed by a presentation on the report’s data and key findings, and a Q&A discussion to delve deeper into the report’s implications.

This event coincides with International Overdose Awareness Day 2024 – the world’s largest campaign to end overdose, which is convened by Penington Institute.

Overdose in Australia: Findings from Australia’s Annual Overdose Report 2024

Tuesday 27 August 2024

12pm – 1pm AEST

Webinar held via Zoom, free admission

This webinar is appropriate for policy makers and public servants, frontline workers, researchers, and other professionals or people who might work or interact with people impacted by overdose or drug use.

Don’t miss this important discussion – register now to secure your place.

Meet our speakers

Dr Marianne Jauncey

Dr Marianne Jauncey

Medical Director, Uniting Medically Supervised Injecting Centre (MSIC)

Dr Marianne Jauncey is a Public Health Physician who has worked at the pointy end of harm reduction for decades. She has been the Medical Director of the Uniting Medically Supervised Injecting Centre (MSIC) since 2008.

She has been instrumental in a number of the service’s achievements. MSIC has both community and political support and in 2010 became a permanent service. The MSIC now has an active consumer action group that goes from strength to strength. The Uniting Church formally decided to advocate for drug law reform and launched their campaign at Town Hall with Richard Branson in 2018. A primary care service for people who inject just opened upstairs above MSIC, and MSIC itself has been present for more than 1.5 million injections without a single death, intervening in over 11,500 overdoses. 

Dr Jauncey is committed to ensuring Uniting MSIC provides unwavering support and meets the needs of its clients beyond merely supervised injection. She is not afraid to speak up or bang a few tables where it is needed. She has conducted many media interviews to improve understanding about harm reduction and the nature drug use and is always willing to get people talking.

Rafaella Caltabiano

Rafaella Caltabiano

Senior Project Officer and report co-author, Penington Institute

Rafaella Caltabiano is a Senior Project Officer at Penington Institute. Prior to this, she held multiple frontline, service coordination and leadership roles in the forensic AOD treatment sector.

Rafaella holds a Master of Criminology and is passionate about health-led, evidence-based approaches to public policy and translating research to practice.

In this webinar, Rafaella will share key insights of the data presented in Australia’s Annual Overdose Report 2024. 

John Ryan

John Ryan

CEO, Penington Institute

John Ryan is a leader in public health and safety and the inaugural CEO of Penington Institute. He actively works to promote sensible approaches to drug use in the community.

John has held numerous non-executive director roles in policy, legal and health related organisations in Australia and internationally. He has also worked as a university researcher, government policymaker, and in frontline service delivery as a needle and syringe program worker.

He has provided non-partisan advice to state and federal governments and was until early 2023 the Chair of the Medically Supervised Injecting Room Review Panel, appointed by the Victorian Government.

John holds a Bachelor of Arts and a Bachelor of Laws from Monash University. In 2012, he received a Churchill Fellowship to study ways to enhance public health approaches to drug policy. 

Our Webinar Details